← Leaderboards
Richard L. Simmons
University Of Pittsburgh At Pittsburgh
$3,786,649
Attributed
$3,786,649
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,786,649 · 6
By mechanism
R01$1,563,890 · 3
U01$1,461,850 · 1
T32$464,420 · 1
R21$296,489 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Timothy R Billiar$30,423,539
- Anuradha Ray$26,369,891
- Fernando Holguin$10,342,142
- Alison Morris$31,399,077
- Fadi G. Lakkis$19,632,585
Others in their field
Top investigators on “Nitric Oxide Synthase”
- Solomon H Snyder · Johns Hopkins University$21,917,530
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$18,412,089
- Jay Louis Zweier · Ohio State University$18,105,943
- Dennis J Stuehr · Cleveland Clinic Foundation$17,503,802
- Costantino Iadecola · Weill Medical Coll Of Cornell Univ$16,413,413
- Philip W Shaul · University Of Texas Sw Med Ctr/Dallas$16,166,249
Research focus
Nitric Oxide SynthaseApoptosisLaboratory RatLaboratory MouseHeart TransplantationEnzyme Induction /RepressionEnzyme ActivityBiotechnologyTissue /Cell CultureAtherosclerosisIsozymesTransplant RejectionHuman SubjectClinical ResearchFree Radical OxygenMiniature SwineCooperative StudyNitric OxideTransfection /Expression VectorGene TherapyBinding SitesCell Cell InteractionCalmodulinImmunoelectron Microscopy
Grant awards (14)
HEPATOCYTE:KUPFFER CELL INTERACTIONS IN SURGICAL SEPSIS$267,488
R01 · FY2003 · GM
iNOS gene therapy to prevent allograft vasculopathy$292,370
U01 · FY2002 · HL
iNOS gene therapy to prevent allograft vasculopathy$292,370
U01 · FY2002 · HL
HEPATOCYTE:KUPFFER CELL INTERACTIONS IN SURGICAL SEPSIS$262,296
R01 · FY2002 · GM
EFFECTORS IN THE ALLOGRAFT RESPONSE$296,489
R21 · FY2001 · AI
iNOS gene therapy to prevent allograft vasculopathy$292,370
U01 · FY2001 · HL
iNOS gene therapy to prevent allograft vasculopathy$292,370
U01 · FY2001 · HL
HEPATOCYTE:KUPFFER CELL INTERACTIONS IN SURGICAL SEPSIS$257,104
R01 · FY2001 · GM
TRAINING IN TRAUMA AND SEPSIS RESEARCH$238,058
T32 · FY2001 · GM
iNOS gene therapy to prevent allograft vasculopathy$292,370
U01 · FY2000 · HL
PATHOGENESIS AND TREATMENT OF EXPERIMENTAL PERITONITIS$280,962
R01 · FY2000 · AI
HEPATOCYTE--KUPFFER CELL INTERACTIONS IN SURGICAL SEPSIS$251,544
R01 · FY2000 · GM
TRAUMA, INFECTION, AND PROSTHETIC BIOMATERIALS$244,496
R01 · FY2000 · GM
TRAINING IN TRAUMA AND SEPSIS RESEARCH$226,362
T32 · FY2000 · GM